About Sepalika
Sepalika is a company based in Mumbai (India) founded in 2016. Sepalika has raised $1.1 million across 2 funding rounds from investors including Accel. Sepalika operates in a competitive market with competitors including Proactive For Her, Newmi, The wellness corner, Gytree and Health Shots, among others.
- Headquarter Mumbai, India
- Stage Minicorn
-
Sectors
Media & EntertainmentHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Moonjur Healthcare Private Limited
- Date of Incorporation 04 Jan, 2016
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$69.31 K (USD)57.21as on Mar 31, 2022
-
Net Profit
-$17.9 K (USD)69.28as on Mar 31, 2022
-
EBITDA
-$8.63 K (USD)78.42as on Mar 31, 2022
-
Total Equity Funding
$1.1 M (USD)
in 2 rounds
-
Latest Funding Round
$321.22 K (USD), Seed
Mar 19, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sepalika
Unlock access to complete
Funding Insights of Sepalika
Sepalika has successfully raised a total of $1.1M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $321.22 thousand completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sepalika
Sepalika has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Accel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Accel is recognized as a leading venture capital firm.
|
Locked | Locked | Locked |
Investor details for Sepalika
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sepalika
Investment portfolio details for Sepalika
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sepalika
Detailed financials for Sepalika
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sepalika Comparisons
Peer comparison for Sepalika
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sepalika
Sepalika operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proactive For Her, Newmi, The wellness corner, Gytree and Health Shots, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personalized confidential healthcare solutions for women are offered.
|
|
| Locked | Locked | Locked |
Products and services for women's health and wellness are provided.
|
|
| Locked | Locked | Locked |
Online platform for health checks, wellness sessions, expert tips, and consultations.
|
|
| Locked | Locked | Locked |
Plant-based nutritional supplements for women's health are provided.
|
|
| Locked | Locked | Locked |
Offers online content on health, fitness, nutrition, and mental well-being.
|
|
| Locked | Locked | Locked |
Online platform for reproductive health information management is provided.
|
Detailed competitors of Sepalika
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sepalika
Complete news archive for Sepalika
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepalika
Sepalika was founded in 2016.
Sepalika is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sepalika is a funded company, having raised a total of $1.1M across 2 funding rounds to date.
Annual revenue of Sepalika is $69.31K as on Mar 31, 2022.
Founded in 2016 in Mumbai, India, Sepalika operates as a healthcare content platform. Research-backed resources on supplements are offered to support immunity, overall health, and mitigation of drug side effects. Searches for supplements related to specific drugs, allergies, or diseases are enabled, along with guidance on lifestyle, dietary supplements, and exercise to address chronic conditions. Focus areas include Type 2 diabetes, arthritis, mental health, depression, and Alzheimers.
Sepalika's top competitors include Proactive For Her, Newmi and Gytree.
Sepalika has 1 investor. Key investors include Accel.
The valuation of Sepalika is $3.72M as of Mar 2018.